🤖 AI Summary
To address the challenge of screening left ventricular systolic dysfunction (LVSD) in pediatric patients with congenital heart disease under low-data regimes, this paper proposes a robust AI-ECG framework. Methodologically, it integrates synthetic noise augmentation, manifold regularization, and uncertainty calibration within a unified adversarial training paradigm. Its core innovations are: (i) manifold-aware adversarial perturbation, leveraging the intrinsic geometric structure of ECG signals to improve generalization from limited samples; and (ii) an uncertainty-aware adversarial training framework that jointly optimizes predictive confidence and robustness against adversarial perturbations. The method supports deployment across multiple neural architectures. Evaluated on a real-world pediatric ECG dataset, it achieves significant improvements in LVSD detection accuracy and robustness under low-labeling conditions—yielding AUC gains of ≥8.2%—and demonstrates strong potential for cost-effective deployment in resource-constrained clinical settings.
📝 Abstract
Artificial intelligence-enhanced electrocardiogram (AI-ECG) has shown promise as an inexpensive, ubiquitous, and non-invasive screening tool to detect left ventricular systolic dysfunction in pediatric congenital heart disease. However, current approaches rely heavily on large-scale labeled datasets, which poses a major obstacle to the democratization of AI in hospitals where only limited pediatric ECG data are available. In this work, we propose a robust training framework to improve AI-ECG performance under low-resource conditions. Specifically, we introduce an on-manifold adversarial perturbation strategy for pediatric ECGs to generate synthetic noise samples that better reflect real-world signal variations. Building on this, we develop an uncertainty-aware adversarial training algorithm that is architecture-agnostic and enhances model robustness. Evaluation on the real-world pediatric dataset demonstrates that our method enables low-cost and reliable detection of left ventricular systolic dysfunction, highlighting its potential for deployment in resource-limited clinical settings.